Loading: 100%
AOXING PHARMACEUTICAL COMPANY, INC. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees (as per )no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker AXNno data available
Financial year endsFY ends End of Juneno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170,000,150,300,450,60
datesClosing price (adj.)
13.10.20170.13
11.10.20170.14
04.10.20170.14
27.09.20170.21
20.09.20170.26
13.09.20170.25
06.09.20170.27
30.08.20170.29
23.08.20170.27
16.08.20170.28
09.08.20170.28
02.08.20170.30
26.07.20170.32
19.07.20170.29
12.07.20170.28
05.07.20170.29
27.06.20170.30
20.06.20170.31
13.06.20170.33
06.06.20170.35
30.05.20170.35
23.05.20170.34
16.05.20170.37
09.05.20170.38
02.05.20170.39
25.04.20170.38
18.04.20170.39
11.04.20170.41
04.04.20170.40
28.03.20170.44
21.03.20170.44
14.03.20170.38
07.03.20170.39
28.02.20170.43
21.02.20170.46
14.02.20170.49
07.02.20170.48
31.01.20170.45
24.01.20170.51
17.01.20170.44
10.01.20170.37
03.01.20170.32
27.12.20160.35
19.12.20160.39
12.12.20160.39
05.12.20160.39
28.11.20160.42
21.11.20160.42
14.11.20160.49
07.11.20160.34
31.10.20160.40
24.10.20160.42
17.10.20160.45
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
0.13n/a
Market Capitalisation
in million USD
10n/a
Enterprise Value
in million USD
13n/a
Common Shares Outstanding
as per Sep 27, 2016
76,209,195n/a
Preferred Shares Outstanding
as per Sep 27, 2016
n/a
Average Basic Shares Outstanding
TTM
73,695,338n/a
Average Diluted Shares Outstanding
TTM
75,467,672n/a
Index Membership
n/a
Business Summary
Aoxing Pharmaceutical Co Inc is a pharmaceutical company. It is engaged in research, development, manufacturing and distribution of narcotics and pain-management products.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 7n/a
Receivables 11n/a
Total Current Assets 27n/a
PP&E 26n/a
Total Assets 56n/a
Accounts Payable 3n/a
Current Debt 11n/a
Total Current Liabilities 38n/a
Long-Term Debt 0n/a
Total Liabilities 38n/a
Total Equity 18n/a
Cash Flow
Depreciation & Amortisation 1n/a
Change in Working Capital -6n/a
Operating Cash Flow -1n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 3n/a
Total Change in Cash 2n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 0.26n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 0.53n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 1.82n/a
Other Ratios
Current Ratio 71.1%n/a
Liabilities to Equity Ratio 211.1%n/a
Debt to Assets Ratio 19.7%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
7
8
11
13
25
32
Sales & Services Revenue
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
Cost of revenue
-3
-3
-5
-7
-6
-8
Cost of Goods & Services
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
Gross Profit
3
5
6
6
20
25
Other Operating Income
0
0
0
0
0
0
Operating Expenses
-8
-6
-13
-9
-11
-18
Selling, General & Administrative
-7
-5
-11
-8
-10
-15
Selling & Marketing
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
Research & Development
-1
-1
-1
-1
0
-3
Depreciation & Amortization
-1
-1
-1
-1
-1
-1
Provision For Doubtful Accounts
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
Operating Income (Loss)
-5
-1
-7
-3
9
6
Non-Operating Income (Loss)
2
4
6
11
12
7
Interest Expense, net
2
2
3
5
6
3
Interest Expense
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
2
3
5
6
4
Pretax Income (Loss), Adjusted
-3
3
0
7
20
13
Abnormal Gains (Losses)
-2
-13
-8
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
Pretax Income (Loss)
-5
-11
-8
7
20
13
Income Tax (Expense) Benefit, net
-3
0
0
0
3
-1
Current Income Tax
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-9
-11
-8
7
23
13
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-9
-11
-8
7
23
13
Minority Interest
0
0
0
0
0
0
Net Income
-8
-11
-8
8
23
12
Preferred Dividends
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Net Income Available to Common Shareholders
-8
-11
-8
8
23
12
Remarks
restated on Oct 15, 2012 n/a
calculated values,
restated on Oct 15, 2013 n/a
calculated values,
restated on Sep 29, 2014 n/a
calculated values,
restated on Oct 13, 2015 n/a
calculated values,
restated on Oct 5, 2016 n/a
calculated values,
restated on Oct 5, 2016 n/a
calculated values,
Balance SheetBS data quality: 95% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
3
4
4
2
5
7
Cash & Cash Equivalents
3
4
4
2
5
7
Short Term Investments
0
0
0
0
0
0
Accounts & Notes Receivable
2
3
3
4
6
11
Accounts Receivable, Net
2
3
3
4
6
11
Notes Receivable, Net
0
0
0
0
0
0
Unbilled Revenues
0
0
0
0
0
0
Inventories
1
2
3
2
3
3
Raw Materials
0
0
0
0
0
0
Work In Process
0
0
0
0
0
0
Finished Goods
0
0
0
0
0
0
Other Inventory
0
0
0
0
0
0
Other Short Term Assets
1
1
2
3
7
6
Prepaid Expenses
1
1
2
3
7
6
Derivative & Hedging Assets
0
0
0
0
0
0
Assets Held-for-Sale
0
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
0
Income Taxes Receivable
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Miscellaneous Short Term Assets
0
0
0
0
0
0
Total Current Assets
7
10
12
11
21
27
Property, Plant & Equipment, Net
27
27
27
26
29
26
Property, Plant & Equipment
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
Long Term Investments & Receivables
0
0
0
0
0
0
Long Term Investments
0
0
0
0
0
0
Long Term Marketable Securities
0
0
0
0
0
0
Long Term Receivables
0
0
0
0
0
0
Other Long Term Assets
22
9
1
1
3
4
Intangible Assets
0
0
0
0
0
0
Goodwill
20
7
0
0
0
0
Other Intangible Assets
1
1
1
1
0
2
Prepaid Expense
0
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
3
2
Derivative & Hedging Assets
0
0
0
0
0
0
Prepaid Pension Costs
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Investments in Affiliates
1
0
0
0
0
0
Miscellaneous Long Term Assets
0
0
0
0
0
0
Total Noncurrent Assets
48
36
28
27
32
29
Total Assets
56
45
40
38
53
56
Liabilities and owners' equity
Payables & Accruals
14 14374399
15 15062538
16 16288749
12 11565954
29 28749513
27 26716199
Accounts Payable
3 2659727
3 2760425
3 3412344
4 3883198
4 3625139
3 2709819
Accrued Taxes
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
12 11714672
12 12302113
13 12876405
8 7682756
25 25124374
24 24006380
Short Term Debt
0 232055
3 3243825
3 3312757
11 11398464
12 12484356
11 11070966
Short Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
0 29308
0 328295
2 2101998
11 11250381
0 5793
0 28365
Deferred Revenue
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
0 29308
0 328295
2 2101998
11 11250381
0 5793
0 28365
Total Current Liabilities
15 14635762
19 18634658
22 21703504
34 34214799
41 41239662
38 37815530
Long Term Debt
0 0
0 0
10 10116027
0 0
0 0
0 0
Long Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
6 5529209
5 5190038
3 3329815
8 7868633
2 1738108
0 340089
Accrued Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 365211
0 367020
0 368751
0 340089
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
6 5529209
5 5190038
3 2964604
8 7501613
1 1369357
0 0
Total Noncurrent Liabilities
6 5529209
5 5190038
13 13445842
8 7868633
2 1738108
0 340089
Total Liabilities
20 20164971
24 23824696
35 35149346
42 42083432
43 42977770
38 38155619
Preferred Equity
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
57 57431268
58 58051854
58 58346721
58 58365321
67 66527089
74 73705960
Common Stock
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
-23 -23009448
-39 -38829768
-56 -55633998
-64 -63849681
-58 -58354968
-56 -56293745
Other Equity
2 1885531
3 2658299
3 2956846
3 2979235
3 3066026
2 1723740
Equity Before Minority Interest
36 36307351
22 21880385
6 5669569
-3 -2505125
11 11238147
19 19135955
Minority Interest
-1 -598598
-1 -615360
-1 -1086035
-2 -1503553
-1 -1175225
-1 -1059983
Total Equity
36 35708753
21 21265025
5 4583534
-4 -4008678
10 10062922
18 18075972
Total Liabilities & Equity
56 55873724
45 45089721
40 39732880
38 38074754
53 53040692
56 56231591
Remarks restated on Oct 15, 2012 n/a restated on Oct 15, 2013 n/a restated on Sep 29, 2014 n/a restated on Oct 13, 2015 n/a restated on Oct 5, 2016 n/a restated on Oct 5, 2016 n/a
Cash Flow StatementCF data quality: 96% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-7
-16
-17
-8
5
2
Net Income
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Depreciation & Amortization
1
1
1
1
1
1
Non-Cash Items
5
14
7
1
-2
2
Stock-Based Compensation
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
Change in Working Capital
-2
-1
0
-1
-1
-6
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
Cash from Operating Activities
-3
-1
-8
-8
3
-1
Change in Fixed Assets & Intangibles
-1
-1
0
0
-3
0
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
Other Investing Activities
1
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
Cash from Investing Activities
-1
-1
0
0
-3
0
Dividends Paid
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
3
9
6
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
0
0
2
3
Increase in Capital Stock
0
0
0
0
2
3
Decrease in Capital Stock
0
0
0
0
0
0
Other Financing Activities
2
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
Cash from Financing Activities
2
3
9
6
3
3
Net Cash Before Disc. Operations and FX
-1
1
0
-2
3
2
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
Net Cash Before FX
-1
1
0
-2
3
2
Effect of Foreign Exchange Rates
0
0
0
0
0
-1
Net Changes in Cash
-1
1
0
-2
3
2
Remarks
restated on Oct 15, 2012 n/a
calculated values,
restated on Oct 15, 2013 n/a
calculated values,
restated on Sep 29, 2014 n/a
calculated values,
restated on Oct 13, 2015 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Oct 5, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo